COVID-19

On Friday, a panel of advisors to the FDA voted to recommend Johnson & Johnson's COVID-19 vaccine, named Ad26.COV2.S, for emergency approval.

Here’s a roundup of the latest coronavirus-related news.

On Friday, an advisory panel will meet to evaluate the vaccine candidate and decide whether to recommend for emergency use authorization.

In our final interview segment, Lee Rosebush dives into improving vaccine distribution, addressing costs, and maintaining records while vaccinating for COVID-19.

In part 2 of our interview, Kaitlyn Rivard, PharmD, leads an insightful discussion on the practical side of administering COVID-19 vaccines.

In part 2 of our interview, Lee Rosebush offers pharmacist-centered guidance on regulation and compliance amid COVID-19 vaccinations.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Members of the MJH Life Sciences™ COVID-19 Coalition recently weighed in on the latest coronavirus disease 2019 (COVID-19) pandemic news.

Lee Rosebush of BakerHostetler law firm discussed how pharmacies can avoid regulatory and compliance issues amid their COVID-19 vaccination programs.

Here’s a roundup of the latest coronavirus-related news.

The MJH Life Sciences™ COVID-19 Coalition is hosting a live webinar event on the legal and ethical considerations of COVID-19 vaccination.

Kaitlyn Rivard, PharmD, infectious diseases clinical pharmacist at the Cleveland Clinic, spoke to Drug Topics about her role in getting their COVID-19 vaccination clinics off the ground.

The US government has purchased 100 million more vaccine doses for COVID-19 to stay ahead of increasing demand.

The presentation discussed the pandemic’s effect on medication safety and provided recommendations to hospitals.

Here's the roundup of the latest coronavirus-related news.

The survey results also showed an increasing willingness among Americans to receive the vaccine.

The emergency use authorization, which was issued to Eli Lilly, grants the use of bamlanivimab in combination with etesevimab for mild-to-moderate COVID-19 infection in adult and pediatric patients.

The FDA advisory committee will meet in 3 weeks to discuss the Janssen investigational vaccine.

Drug Topics interviewed Karen Mackinnon and Sara Revolinski from the Medical College of Wisconsin School of Pharmacy about how their pharmacy students have been rising to meet the demand of the pandemic by administering COVID-19 vaccines.

Here's the roundup of the latest coronavirus-related news.

In this article, we will review the evidence describing a possible link between vitamin D and COVID-19.

Starting February 11, federal vaccine supplies will be delivered directly to select pharmacies, according to the announcement.

Here’s a roundup of the latest coronavirus-related news.

The single-dose adenovirus-based vaccine candidate produced protective effects against moderate-to-severe COVID-19, as well as against multiple virus variants.

Experts presented safety data on the 2 currently authorized COVID-19 vaccines during a meeting of the CDC’s Advisory Committee on Immunization Practices.

The latest Heart Disease and Stroke Statistical Update highlighted pandemic-related trends that may impact cardiovascular disease mortality for years.

A recent study examined patient characteristics and factors affecting COVID-19 mortality in individuals with diabetes.

Eli Lilly’s BLAZE-1 study produced strong evidence that treatment with bamlanivimab plus etesvimab reduced risk of COVID-19 hospitalizations and death.

The CDC’s Advisory Committee on Immunization Practices issued updates to its interim recommendations for mRNA COVID-19 vaccines.

The Biden administration announced efforts to boost COVID-19 vaccination supply and increase transparency.